India to Laos: Gefitinib Export Trade Route

The India to Laos Gefitinib corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $9.8K USD. The route is dominated by ASPIDA LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's gefitinib manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $2.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with gefitinib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 23.7%, placing it at rank #20 among India's top gefitinib export destinations globally.

On the import side, key buyers of Indian gefitinib in Laos include MS KHUAN SAIMANEEBIGBANG INTERNATIONAL TRADE CO LIMITED, ALLIEVA PHARMA LAO CO LTD, MR JUNNY WATTAY INTERNATIONAL. MS KHUAN SAIMANEEBIGBANG INTERNATIONAL TRADE CO LIMITED is the single largest importer with 2 shipments valued at $4.8K USD.

India's gefitinib exports to Laos are driven primarily by a handful of large-scale manufacturers. ASPIDA LIFE SCIENCES PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Laos benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ASPIDA LIFE SCIENCES PRIVATE LIMITED, TAURED CORPORATION — together account for 100% of total trade value on this route. The average shipment value of $2.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumptiongefitinib tablets i.p. 1*30 tablets geftinat batch no . 702817 and harmless medicine for human consumptiongefitinib tablets ip 3*10tablets iressa 250 mg batch no . 60044162 mf, suggesting that buyers in Laos tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MS KHUAN SAIMANEEBIGBANG INTERNATIONAL TRADE CO LIMITED is the largest importer with 2 shipments worth $4.8K USD — representing 49% of all gefitinib imports from India on this route.